Search Articles

View query in Help articles search

Search Results (1 to 10 of 18 Results)

Download search results: CSV END BibTex RIS


Peer Review for “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”

Peer Review for “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”

This is the peer-review report for “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis.”

Anonymous

JMIRx Med 2024;5:e59120

Authors’ Response to Peer Reviews of “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”

Authors’ Response to Peer Reviews of “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”

This is the authors’ response to peer-review reports for “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis.”

Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan

JMIRx Med 2024;5:e58273

Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

In this study, we evaluated thyroid hyperplasia and neoplasm–related AEs that are reported as being associated with GLP-1 RA monotherapy when compared to sodium-glucose cotransporter-2 (SGLT-2) inhibitors monotherapy. SGLT-2 inhibitors, a class of drugs that work by blocking renal glucose reabsorption, were selected as the control cohort due to their comparable indication in diabetes treatment guidelines. We analyzed GLP-1 RAs individually and as a class.

Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan

JMIRx Med 2024;5:e55976

Improvements in Neoplasm Classification in the International Classification of Diseases, Eleventh Revision: Systematic Comparative Study With the Chinese Clinical Modification of the International Classification of Diseases, Tenth Revision

Improvements in Neoplasm Classification in the International Classification of Diseases, Eleventh Revision: Systematic Comparative Study With the Chinese Clinical Modification of the International Classification of Diseases, Tenth Revision

This study analyzes the changes between the ICD-10-CCM and ICD-11 in terms of coding features, classification features, and expression features in neoplasm classification and hopes to provide evidence supporting the transition in China.

Yicong Xu, Jingya Zhou, Hongxia Li, Dong Cai, Huanbing Zhu, Shengdong Pan

Interact J Med Res 2024;13:e52296

Clinical Decision Support System for All Stages of Gastric Carcinogenesis in Real-Time Endoscopy: Model Establishment and Validation Study

Clinical Decision Support System for All Stages of Gastric Carcinogenesis in Real-Time Endoscopy: Model Establishment and Validation Study

In brief, between 2010 and 2017, we enrolled consecutive patients with any type of gastric neoplasm discovered during upper gastrointestinal endoscopy and pathologically confirmed at the Chuncheon Sacred Heart hospital. We enrolled all patients diagnosed with atrophy or IM during upper gastrointestinal endoscopy at Hallym University Chuncheon Sacred Heart hospital between 2019 and 2021 to add preneoplastic conditions to the baseline input data. These images were classified as either atrophy or IM.

Eun Jeong Gong, Chang Seok Bang, Jae Jun Lee, Hae Min Jeong, Gwang Ho Baik, Jae Hoon Jeong, Sigmund Dick, Gi Hun Lee

J Med Internet Res 2023;25:e50448

Smartphone-Based Psychotherapeutic Interventions in Blended Care of Cancer Survivors: Nested Randomized Clinical Trial

Smartphone-Based Psychotherapeutic Interventions in Blended Care of Cancer Survivors: Nested Randomized Clinical Trial

Inclusion criteria for the entire nonrandomized study were (1) age≥18 years, (2) sufficient knowledge of spoken German, (3) having received curatively intended treatment for any malignant neoplasm, (4) suffering from bodily disturbances, (5) primary treatment being completed at least 3 months prior to recruitment, (6) an Eastern Cooperative Oncology Group performance score of 0-1 [16], (7) an anticipated life expectancy of ≥12 months, and (8) the anticipated capacity to participate in the baseline assessment

Gunther Meinlschmidt, Astrid Grossert, Cornelia Meffert, Noa Roemmel, Viviane Hess, Christoph Rochlitz, Miklos Pless, Sabina Hunziker, Brigitta Wössmer, Ulfried Geuter, Rainer Schaefert

JMIR Cancer 2023;9:e38515